✦ LIBER ✦

Atypical Chronic Myeloproliferative Disorders: Genes and Imatinib-Sensitive Targets

✍ Scribed by Giovanni Martinelli

Book ID: 117822009
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 87 KB
Volume: 44
Category: Article
ISSN: 1532-8686
DOI: 10.1053/j.seminhematol.2007.02.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of Imatinib-Sensitive Tyrosine Kina

Role of Imatinib-Sensitive Tyrosine Kinases in the Pathogenesis of Chronic Myeloproliferative Disorders

✍ Daniel J. DeAngelo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 780 KB

Anagrelide and imatinib mesylate combina

Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders

✍ Apostolia M. Tsimberidou; Dawn E. Colburn; Mary Alma Welch; Jorge E. Cortes; Srd 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 187 KB

Beyond chronic myelogenous leukemia : Po

Beyond chronic myelogenous leukemia : Potential role for imatinib in Philadelphia-negative myeloproliferative disorders

✍ Jorge Cortes; Hagop Kantarjian 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

## Abstract The myeloproliferative disorders (MPDs) are chronic malignant conditions originating from the clonal expansion of a multipotential hematopoietic stem cell. These diseases include polycythemia vera (PV), essential thrombocythenia, atypical chronic myeloid leukemia, idiopathic hypereosino

Fusion of PRKG2 and SPTBN1 to the platel

Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders

✍ Genevieve Gallagher; Douglas E. Horsman; Peter Tsang; Donna L. Forrest 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 315 KB

RAS Gene Mutations in Acute and Chronic

RAS Gene Mutations in Acute and Chronic Myelocytic Leukemias, Chronic Myeloproliferative Disorders, and Myelodysplastic Syndromes

✍ Johannes W. G. Janssen, Ada C. M. Steenvoorden, John Lyons, Bernd Anger, Jörg U. 📂 Article 📅 1987 🏛 National Academy of Sciences 🌐 English ⚖ 911 KB

Targets and effectors of the cellular re

Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia

✍ Nicholas J. Donato; Dexing Fang; Hanshi Sun; Diane Giannola; Luke F. Peterson; M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 552 KB